# MiMedx Group, Inc. (NASDAQ: MDXG), Kennesaw, GA – FDA Inspections

Source: https://www.keypedia.com/companies/mimedx-group-inc/48cc856a-f21d-4488-bbbd-4428f7bf1308

> Inspection records and compliance data for MiMedx Group, Inc. in Kennesaw, Georgia. 3 FDA inspections on record (1 OAI), 1 Form 483, 1 warning letter, last inspected March 02, 2023. Publicly traded as NASDAQ: MDXG.

---

## Details

- Name: MiMedx Group, Inc.
- FEI Number: 3009814715
- Address Line 1: 300 Townpark Dr Nw Ste 260
- City: Kennesaw
- State: Georgia
- Zip Code: 30144
- Country Name: United States
- Address: 300 Townpark Dr Nw Ste 260, Kennesaw, Georgia 30144, United States
- Country: United States

## Stock

- Stock ticker: MDXG
- Exchange: NASDAQ
- Share price: $3.24
- Market cap: $472.8M
- Price as of: November 13, 2026

## Related Documents

- [483 - MiMedx Group, Inc. - 2023-03-02](https://www.keypedia.com/records/483/mimedx-group-inc/3f7d18d7-7a56-4f50-9e88-41173a958051) — source: FDA, date: March 2, 2023
- [WARNING_LETTER - MiMedx Group, Inc. - 2023-03-02](https://www.keypedia.com/records/warning_letter/mimedx-group-inc/a3e8fe0c-5d5b-450b-820f-3c8e6d7fd532) — source: FDA, date: March 2, 2023
- [FDA Inspection 1198732 - MiMedx Group, Inc. - 2023-03-02](https://www.keypedia.com/records/fda_inspections/mimedx-group-inc/495a9599-303b-4b00-9b51-d82febc2ac7a) — classification: Official Action Indicated (OAI), source: FDA, date: March 2, 2023
- FDA Inspection 1198732 - MiMedx Group, Inc. - 2023-03-02 — classification: No Action Indicated (NAI), source: FDA, date: March 2, 2023
- [483 - MiMedx Group, Inc. - 2019-12-12](https://www.keypedia.com/records/483/mimedx-group-inc/d4786ad2-6f75-4bb2-af26-0641376accaa) — source: FDA, date: December 12, 2019
- [FDA Inspection 1112843 - MiMedx Group, Inc. - 2019-12-12](https://www.keypedia.com/records/fda_inspections/mimedx-group-inc/1435ccd2-4ab5-4cff-850f-38e6beb19f63) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 12, 2019
- FDA Inspection 1069242 - MiMedx Group, Inc. - 2018-09-26 — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2018

## Related Companies

- [Hemarus LLC](https://www.keypedia.com/companies/hemarus-llc/7e3cb278-9e15-4ba3-a74b-b27e6993381b)
- [Conceive Fertility Center](https://www.keypedia.com/companies/conceive-fertility-center/61216c92-e61d-4550-9721-2e424669dde8)
- [New York Blood Center Inc](https://www.keypedia.com/companies/new-york-blood-center-inc/ffed078a-99a5-4934-961a-8262fee09c76)
- [Stratus BioSystems, LLC](https://www.keypedia.com/companies/stratus-biosystems-llc/19f91252-2572-4e95-af09-c6ab599ed544)
- [Newton Implant Systems, Inc.](https://www.keypedia.com/companies/newton-implant-systems-inc/1f0919c6-0711-4f63-bc4d-d6bbb7afc011)
- [Vitti Labs, LLC](https://www.keypedia.com/companies/vitti-labs-llc/d4b6cc08-4904-4caf-ba28-ad1c8bf74a74)
- [Marlborough Hospital](https://www.keypedia.com/companies/marlborough-hospital/bf807868-a89c-4599-9a03-b79bb0a8a3ea)
- [Elite IVF & Fertility Solutions LLC](https://www.keypedia.com/companies/elite-ivf-fertility-solutions-llc/fc636edf-b6de-440e-8f65-3f89c222b32e)
- [Re-Gen Active Lab Inc](https://www.keypedia.com/companies/re-gen-active-lab-inc/348e9f01-5a00-415d-9322-83f379a0e943)
- [Clinical Laboratories of HI at Wilcox Mem Hospital (Lab)](https://www.keypedia.com/companies/clinical-laboratories-of-hi-at-wilcox-mem-hospital-lab/d66777fc-05d8-4b19-8a00-6d0031d4b633)

## Related Officers

- [Nicholas M Smith](https://www.keypedia.com/people/nicholas-m-smith/bacbf9f6-b1a6-41b7-bb31-1d67be012783)
- [Investigator](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)
- [Marla A. Cassidy](https://www.keypedia.com/people/marla-a-cassidy/d2859ca5-e77b-4385-9a96-4c785f3ac4c6)
- [Christopher J. Adams](https://www.keypedia.com/people/christopher-j-adams/f7010846-7fd1-4ee8-901a-1015656fea0a)
- [Program Division Director](https://www.keypedia.com/people/michael-w-roosevelt/136906d6-8e93-4080-acf9-5d48d4509a80)
